The authors report 11 patients with genetically determined medullary microc
arcinomas. Nine patients were either children or adolescents and two patien
ts were young adults. The youngest patient was 7 years old and the oldest w
as 34 years of age (mean age, 15.4 yrs). The preoperative diagnosis was bas
ed on family history and elevated serum calcitonin levels. In addition, six
patients had RET protooncogene mutations in exons 10, 11, and 16. Two pati
ents who had the RET protooncogene mutations did not have serum calcitonin
measurements. Nine patients had bilateral medullary microcarcinomas (<1.0 c
m), whereas the two patients with unilateral tumors demonstrated multifocal
disease. The principle microscopic differences between these genetically d
etermined medullary microcarcinomas and larger sporadic (>1 cm) medullary c
arcinomas were the low incidence of stromal desmoplasia and amyloid deposit
ion, the high incidence of C-cell hyperplasia, and the low incidence of lym
ph node metastases. Only one patient, a 34-year-old man, presented with lym
ph node metastases. All patients remain disease free 11 to 70 months after
diagnosis. This small series of thyroid microcarcinomas illustrates the imp
act molecular diagnostics is having on the management and prognosis of gene
rically determined medullary carcinoma.